A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients

NCT02572947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Dolutegravir
Monotherapy
Treatment Efficacy

Interventions

DRUG: Dolutegravir

Sponsor

Calmy Alexandra